Literature DB >> 27070489

ING4 Inhibits Proliferation and Induces Apoptosis in Human Melanoma A375 Cells via the Fas/Caspase-8 Apoptosis Pathway.

Yanli Ma1, Xue Cheng, Fei Wang, Jisheng Pan, Jing Liu, Hongxiao Chen, Yongchen Wang, Limin Cai.   

Abstract

BACKGROUND: Inhibitor of growth 4 (ING4) plays a role in regulating the cell cycle, apoptosis, cell invasion and migration, but the mechanisms involved remain to be elucidated.
OBJECTIVE: To explore how ING4 affects human malignant melanoma A375 cells.
METHODS: Recombinant lentiviral vectors (A375/pLenO-GTP-ING4) were constructed and transfected into A375 cells (experimental group). The impact of ING4 on the proliferation and apoptosis of A375 cells was investigated in in vitro and in vivo experiments in mice using the MTT assay and flow cytometry.
RESULTS: In the experimental group, optical density was lower and apoptotic cells were more frequent from days 2-5 (p = 0.000 and p < 0.01); there were smaller xenografts and more apoptotic cells in mice (all p < 0.05); moreover, increased levels of Fas, cleaved caspase-8 and caspase-3, and decreased levels of FasL and procyclic acidic repetitive protein were observed in vitro and in vivo.
CONCLUSION: ING4 might suppress proliferation and enhance apoptosis in human malignant melanoma cells by activating Fas-induced apoptosis in a caspase-8-dependent pathway.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27070489     DOI: 10.1159/000444050

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  7 in total

1.  ING4 expressing oncolytic vaccinia virus promotes anti-tumor efficiency and synergizes with gemcitabine in pancreatic cancer.

Authors:  Yinfang Wu; Xiaozhou Mou; Shibing Wang; Xing-E Liu; Xiaodong Sun
Journal:  Oncotarget       Date:  2017-09-20

2.  MicroRNA-122 regulates caspase-8 and promotes the apoptosis of mouse cardiomyocytes.

Authors:  Z W Zhang; H Li; S S Chen; Y Li; Z Y Cui; J Ma
Journal:  Braz J Med Biol Res       Date:  2017-02-06       Impact factor: 2.590

3.  Efficacy of combining ING4 and TRAIL genes in cancer-targeting gene virotherapy strategy: first evidence in preclinical hepatocellular carcinoma.

Authors:  A Galal El-Shemi; A Mohammed Ashshi; E Oh; B-K Jung; M Basalamah; A Alsaegh; C-O Yun
Journal:  Gene Ther       Date:  2017-09-19       Impact factor: 5.250

4.  Effect of bevacizumab on expression level of GLI1 and ING4 in colon cancer animal model.

Authors:  Bing Suo; Caiyu Wu; Fen Mei
Journal:  Oncol Lett       Date:  2020-05-28       Impact factor: 2.967

5.  miR-650 promotes non-small cell lung cancer cell proliferation and invasion by targeting ING4 through Wnt-1/β-catenin pathway.

Authors:  Xiangqin Tang; Yanjun Ding; Xiaoqing Wang; Xiuzhen Wang; Lin Zhao; Hongmei Bi
Journal:  Oncol Lett       Date:  2019-09-04       Impact factor: 2.967

Review 6.  ING Tumour Suppressors and ING Splice Variants as Coregulators of the Androgen Receptor Signalling in Prostate Cancer.

Authors:  Anna Melekhova; Aria Baniahmad
Journal:  Cells       Date:  2021-09-29       Impact factor: 6.600

Review 7.  The essential role of tumor suppressor gene ING4 in various human cancers and non-neoplastic disorders.

Authors:  Yang Du; Yan Cheng; Guanfang Su
Journal:  Biosci Rep       Date:  2019-01-30       Impact factor: 3.840

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.